Pantheon Vision attended the BioHealth Capital Region Forum last week where Glenn Youngkin was named BIO’s Governor of the Year. Great event with companies from the Maryland, Virginia and DC regions. #innovation #Baltimore
Pantheon Vision
Medical Equipment Manufacturing
Baltimore, MD 275 followers
Restoring the joy of sight by eliminating corneal blindness
About us
Pantheon Vision is an early stage medical device company developing bioengineered solutions to reduce the reliance on donor tissue to address corneal blindness.
- Website
-
http://www.pantheonvision.com
External link for Pantheon Vision
- Industry
- Medical Equipment Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Baltimore, MD
- Type
- Privately Held
- Founded
- 2023
- Specialties
- Ophthalmology and Medical Device
Locations
-
Primary
Baltimore, MD, US
Employees at Pantheon Vision
-
Michelle Bockman
Chief Executive Officer | Co-Founder | Enterprise Go-To-Market Leadership | Profit and Loss Growth Strategist | Advisor |Technologist
-
Marty Chomiak
Chief Marketing Officer Pantheon Vision Inc Founding President at 30 Nirth Explorer
-
John Sheets, Ph.D.
President/CEO/Co-Founder Pantheon Vision , Principal at ThoughtStorm Innovation and Consultant at NDA Partners
-
Susanne Manz
Consultant | Educator | Author
Updates
-
Pantheon Vision attended the BioHealth Capital Region Forum this week with Gov. Wes Moore as the keynote speaker on businesses bringing innovation and entrepreneurship to the metro DC region. #innovation #Baltimore
-
Thank you Veeral Sheth, MD, MBA, FASRS for having John Sheets, Ph.D., CEO and President of Pantheon Vision on the podcast - great conversation on alternative solutions to prevent corneal blindness.
Corneal blindness poses a significant public health challenge, particularly in low- and middle-income countries, where limited access to eye care contributes to a high disability burden and impacts both quality of life and economic productivity. In our latest episode of New Insight, I am joined by John Sheets, Ph.D., co-founder of Pantheon Vision, an innovative organization developing bioengineered solutions to eliminate corneal blindness and restore sight to millions. Pantheon Vision aims to reduce the reliance on donated corneal tissues and improve outcomes in vision restoration. Our discussion delves into Sheets' extensive experience in the ophthalmology industry, including roles at Alcon, Bausch Lomb, Stealth Therapeutics, and the FDA, and how his background uniquely positions him to lead Pantheon Vision in tackling this global health issue. Catch the full episode on HCPLive.com, YouTube, or wherever you listen to podcasts! #Healthcare #Ophthalmology #CornealBlindness #PublicHealth #Innovation #Bioengineering #Podcast
-
Thank you @HCPNewslive 's #NewInsight with Veeral Sheth, MD, MBA, FASRS for having John Sheets, Ph.D., CEO of Pantheon Vision on the podcast to discuss our plans for corneal transplant alternatives. https://lnkd.in/eD5ZKvxf
New Insight: A Look at Corneal Transplant Alternatives w/ John Sheets, PhD
hcplive.com
-
Thank you Ophthalmology Futures Forum 2024, Barcelona, Spain for having Pantheon Vision's CEO John Sheets, Ph.D. present on our commitment and path to eliminating corneal blindness. Great seeing so many industry colleagues at this key ophthalmology meeting. #EuropeanForum2024 #cornealblindness
-
Come see Pantheon Vision's CEO John Sheets, Ph.D. present at the upcoming Ophthalmic Futures Forum in Barcelona Spain, Sept 5. We hope to meet you there!
-
Pantheon Vision's CEO John Sheets, Ph.D. is proud to present at the upcoming Ophthalmology Futures Forum in Barcelona Spain, Sept 5. We hope to meet you there! #EuropeanForum2024 #cornealblindness
-
Thank you to Mark Dlugoss host of The Ophthalmic Project by Ophthalmology 360® for having Pantheon Vision's President and CEO John Sheets, Ph.D., on the podcast - great conversation on corneal transplants and the need for new solutions. Listen here: https://lnkd.in/eWsX4SSH
John W. Sheets, PhD, discusses Pantheon Vision’s bioengineering solutions for corneal transplants - Ophthalmology 360
https://ophthalmology360.com
-
Pantheon Vision's Marty Chomiak and Daniel Stonko thanks J.P. Morgan Life Sciences for hosting the Baltimore Life Sciences Networking Reception. It was great meeting colleagues in the #Baltimore life science community and especially Brett Shealy, Exec Dir, @jpmorgan Life Sciences.
-
We asked Pantheon Vision's COO Daniel Stonko: What is your motivation for Pantheon Vision's mission? "I spent the earlier part of my career focused on ocular tissue banking, specifically addressing corneal blindness using the current standard of care, which hasn’t significantly changed in over 100 years. Issues with traditional transplantation became apparent while traveling to underserved countries, where millions of patients annually are unnecessarily going blind, and across the US, where patients that do receive treatment have suboptimal outcomes. A majority of patients' vision could have been saved or have improved outcomes through alternative sustainable, scalable and effective solutions. Through Pantheon Vision, we are driven to develop a bioengineered corneal implant that utilizes emerging technologies and materials, with a global strategy to bring this product to patients around the world."